# ARCUTIS BIOTHERAPEUTICS INC (ARQT)

> Institutional ownership reported to the SEC as of Q3 2026, from Form 13F filings. Source: https://holderbook.com/stocks/ARQT/

- Reporting holders: 7
- Reported value: $355.4K
- Held through calls: 0.0%
- Held through puts: 0.0%

A 13F reports long US equity positions only. Shorts, bonds, foreign listings and cash are not visible here, and positions are disclosed up to 45 days after the quarter ends.

## Largest holders

| Manager | Value | Shares | Share of their book | Quarters held |
|---|---|---|---|---|
| [TOTH FINANCIAL ADVISORY CORP](https://holderbook.com/funds/866780-toth-financial-advisory-corp/) | $284.7K | 10,770 | 0.0% | 1 |
| [GAMMA Investing LLC](https://holderbook.com/funds/2010235-gamma-investing-llc/) | $35.3K | 1,337 | 0.0% | 12 |
| [Farther Finance Advisors, LLC](https://holderbook.com/funds/1992825-farther-finance-advisors-llc/) | $23.6K | 893 | 0.0% | 12 |
| [GK Wealth Management LLC](https://holderbook.com/funds/2069222-gk-wealth-management-llc/) | $8.6K | 325 | 0.0% | 1 |
| [Versant Capital Management, Inc](https://holderbook.com/funds/1735057-versant-capital-management-inc/) | $2.9K | 108 | 0.0% | 9 |
| [GILPIN WEALTH MANAGEMENT, LLC](https://holderbook.com/funds/2058144-gilpin-wealth-management-llc/) | $186 | 7 | 0.0% | 1 |
| [Davis Capital Management](https://holderbook.com/funds/1811806-davis-capital-management/) | $159 | 6 | 0.0% | 1 |

## Quarter by quarter

| Quarter | Holders | Reported value |
|---|---|---|
| Q3 2026 | 7 | $355.4K |
| Q2 2026 | 276 | $3.7B |
| Q1 2026 | 269 | $3.2B |
| Q4 2025 | 285 | $3.8B |
| Q3 2025 | 240 | $2.4B |
| Q2 2025 | 231 | $1.8B |
| Q1 2025 | 244 | $2.0B |
| Q4 2024 | 210 | $1.8B |
| Q3 2024 | 190 | $1.2B |
| Q2 2024 | 189 | $1.2B |
| Q1 2024 | 167 | $1.3B |
| Q4 2023 | 133 | $348.1M |